On September 29, 2025, the Cambodian news site "Find Your News" reported on the journey of 5-year-old Ponleu Vireakbot (nicknamed Charlie) in his fight against stage 4 medulloblastoma (a malignant brain tumor).
Read the full report at Find Your News
Charlie was diagnosed with a brain tumor on February 10, 2024, and subsequently underwent surgery in Thailand to remove the tumor. Following the surgery, he received 30 sessions of radiotherapy and 10 courses of chemotherapy. Unfortunately, the tumor recurred, and doctors have recommended palliative care.
His family persevered, exploring alternative treatment methods, ultimately opting for 23Century, a Malaysia-based facility. At this facility, Charlie underwent immunotherapy utilizing NK (Natural Killer) cells. The treatment outcomes were highly satisfactory, with tumor markers decreasing from 3.6 to 2.1. His family reported that, following the treatment, Charlie's condition significantly improved, pain was reduced, and his quality of life was enhanced.
Learn more about NK Cell Therapy
After more than a year of battling his illness, treatment at 23Century provided renewed hope for Charlie and his family. This narrative of struggle and recovery highlights the immense potential of NK cell immunotherapy in addressing challenging cancers.
